Denemek ALTIN - Özgür
Faster drug trials in works as India eyes export gains
Mint Mumbai
|September 04, 2025
New drugs may reach chemists quicker and clinical trials kick off earlier, with the Union health ministry drafting rules to cut the time to process approvals by half and help India expand its footprint in the $1.55 billion global clinical trials industry.

The proposed changes will streamline the process for testing licences and certain studies by replacing the old licensing system with a faster online notification system, the health ministry said on Wednesday.
This will require an amendment to India's New Drugs and Clinical Trials Rules, 2019, potentially reducing the application processing time from 90 to 45 working days.
A key change proposed in the draft New Drugs and Clinical Trials (Amendment) Rules, 2025 allows firms to start studies on drugs meant for export with an online notification if the product's been approved in major markets such as the US, UK, EU, Japan, Australia and Canada.
These studies will be limited to a maximum of 48 healthy adult volunteers.
The ministry said the changes aim to reduce licence applications by about 50%.
The public has 30 days to submit comments.
Bu hikaye Mint Mumbai dergisinin September 04, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Mumbai'den DAHA FAZLA HİKAYE
Mint Mumbai
H-IB fee hike Trump's second blow to gems & jewellery firms
Losing sparkle
2 mins
October 13, 2025

Mint Mumbai
Slow drive for e-trucks as local sourcing rule bites
E-truck manufacturers wary of ambitious indigenization due to concerns over tepid demand
2 mins
October 13, 2025
Mint Mumbai
YOGA, AYURVEDA—INDIA CAN LEAD THE WISDOM ECONOMY
I was watching a video of a meditation studio in Manhattan when it struck me yet again. Twenty people, mostly American professionals, sitting cross-legged on expensive mats, were following breathing techniques that our grandparents and ancestors practised every morning.
2 mins
October 13, 2025

Mint Mumbai
Existing investors pour in $40 million into Dezerv
Wealth management platform Dezerv has raised ₹350 crore (about $40 million) in a new funding round from its existing investors, the company's top executive told Mint.
1 mins
October 13, 2025
Mint Mumbai
THE RECIPE OF TRUMPING ODDS: THE RSS PLAYBOOK
I have been watching Rashtriya Swayamsevak Sangh (RSS), now in its 101st year, for more than 50 years. Today, when its swayamsevaks (volunteers) are in power in Delhi and 14 other state capitals, there’s a curiosity about the secret of its success.
3 mins
October 13, 2025
Mint Mumbai
Can a hint of silver find place in your precious metals strategy?
Silver can deliver short-term gains but is more volatile than gold; limit exposure to 2-4% due to its inherent risks
5 mins
October 13, 2025
Mint Mumbai
US negotiators push for e-comm inventory model
Embassy in New Delhi said, “Due to the lapse in appropriations in the US government, we are unable to respond to routine press inquiries.”
1 mins
October 13, 2025

Mint Mumbai
Fashion tech firms struggle for funding fit
A few players are showing promise by combining AI with commerce
2 mins
October 13, 2025
Mint Mumbai
Thinking Machines Lab co-founder departs for Meta
A co-founder of Mira Murati ’s Thinking Machines Lab has left to join Meta Platforms, the startup confirmed Saturday.
2 mins
October 13, 2025

Mint Mumbai
Traffic data to guide road project model
The Centre plans to mandate awarding new highway projects under the build-operate-transfer (BOT) model if the traffic data, generated through the electronic toll collection system FASTag shows that private developers can earn at least 15% annual returns from toll collections, two people aware of the matter said.
2 mins
October 13, 2025
Listen
Translate
Change font size